Search Result "glutamatergic agents"
Zinc in the Glutamatergic Theory of Depression
Journal: Current Neuropharmacology
Volume: 13 Issue: 4 Year: 2015 Page: 505-513
Author(s): Katarzyna Mlyniec
Pharmacological Properties of Glutamatergic Drugs Targeting NMDA Receptors and their Application in Major Depression
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 10 Year: 2013 Page: 1898-1922
Author(s): Gianluca Serafini,Maurizio Pompili,Marco Innamorati,Yogesh Dwivedi,Goutam Brahmachari,Paolo Girardi
An Update on Glutamatergic System in Suicidal Depression and on the Role of Esketamine
Journal: Current Topics in Medicinal Chemistry
Volume: 20 Issue: 7 Year: 2020 Page: 554-584
Author(s): Domenico De Berardis,Carmine Tomasetti,Maurizio Pompili,Gianluca Serafini,Federica Vellante,Michele Fornaro,Alessandro Valchera,Giampaolo Perna,Umberto Volpe,Giovanni Martinotti,Silvia Fraticelli,Massimo Di Giannantonio,Yong-Ku Kim,Laura Orsolini
Glutamatergic Dysfunction-Newer Targets for Anti-Obsessional Drugs
Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 2 Issue: 1 Year: 2007 Page: 47-55
Author(s): Sagnik Bhattacharyya, Koushik Chakraborty
Glutamatergic Neurotransmission As Molecular Target of New Anticonvulsants
Journal: Current Topics in Medicinal Chemistry
Volume: 12 Issue: 9 Year: 2012 Page: 971-993
Author(s): Rosaria Gitto,Laura De Luca,Sara De Grazia,Alba Chimirri
Glutamatergic Targets for Enhancing Extinction Learning in Drug Addiction
Journal: Current Neuropharmacology
Volume: 8 Issue: 4 Year: 2010 Page: 394-408
Author(s): R. M. Cleva, J. T. Gass, J. J. Widholm, M. F. Olive
Allosteric Modulators for the Treatment of Schizophrenia: Targeting Glutamatergic Networks
Journal: Current Topics in Medicinal Chemistry
Volume: 13 Issue: 1 Year: 2013 Page: 26-54
Author(s): Frank S. Menniti, Craig W. Lindsley, P. Jeffrey Conn, Jayvardhan Pandit, Panayiotis Zagouras, Robert A. Volkmann
Ketamine and Glutamatergic Compounds: Exploring Biomarkers and Mechanisms Related to Rapid Antidepressant Action
Ebook: Frontiers in Drug Discovery
Volume: 2 Year: 2017
Author(s): Gislaine Z. Réus,Helena M. Abelaira,Gerard Sanacora,João Quevedo
Doi: 10.2174/9781681084732117020010
Targeting Glutamatergic Signaling for the Development of Novel Therapeutics for Mood Disorders
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 1 Year: 2009 Page: 1595-1611
Author(s): Rodrigo Machado-Vieira, Giacomo Salvadore, Lobna A. Ibrahim, Nancy Diaz-Granados, Carlos A. Zarate Jr.
Novel Therapies for Schizophrenia: Understanding the Glutamatergic Synapse and Potential Targets for Altering N-methyl-D-aspartate Neurotransmission
Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 4 Issue: 3 Year: 2009 Page: 220-238
Author(s): Christina Hui, Brian Wardwell, Guochuan E. Tsai